CN1197599C - Medicine for treating rheumatoid arthritis and tetanic rachitis - Google Patents

Medicine for treating rheumatoid arthritis and tetanic rachitis Download PDF

Info

Publication number
CN1197599C
CN1197599C CN 02112177 CN02112177A CN1197599C CN 1197599 C CN1197599 C CN 1197599C CN 02112177 CN02112177 CN 02112177 CN 02112177 A CN02112177 A CN 02112177A CN 1197599 C CN1197599 C CN 1197599C
Authority
CN
China
Prior art keywords
medicine
time
hour
root
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 02112177
Other languages
Chinese (zh)
Other versions
CN1435205A (en
Inventor
谢志良
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 02112177 priority Critical patent/CN1197599C/en
Publication of CN1435205A publication Critical patent/CN1435205A/en
Application granted granted Critical
Publication of CN1197599C publication Critical patent/CN1197599C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses a medicine for treating patients with rheumatoid arthritis and ankylosing spondylitis. Alternate treatment is carried out by adopting Chinese herbal medicines in two formulae. The medicine has the components according to the proportion(100 portions) by weight: a first group: 70 to 90 portions of red azalea root and 10 to 20 portions of fig; a second group: 70 to 90 portions of honeysuckle and 10 to 20 portions of licorice root. A preparation process comprises: in the first group, the red azalea root and the fig are washed according to the proportion and are put in a pot, and a proper amount of water is added; the red azalea root and the fig are decocted by mild fire for half an hour, and then are filtered for later use; the red azalea root and the fig are decocted for 40 minutes at the second time and the third time, and are decocted for an hour at the fourth time, and the liquid of the red azalea root and the fig is filtered to obtain the medicine; in the second group, according to the proportion, the honeysuckle and the licorice root are washed and put in a pot, and a proper amount of water is added; the honeysuckle and the licorice root are decocted by mild fire for half an hour, and then are filtered for later use; the honeysuckle and the licorice root are decocted for 40 minutes at the second time and the third time, and are decocted for an hour at the fourth time, and the liquid of the honeysuckle and the licorice roots is filtered to obtain the medicine. The medicine is suitable for the treatment of the patients with rheumatoid arthritis and ankylosing spondylitis.

Description

The medicine of one cover treatment rheumatoid arthritis, ankylosing spondylitis
Technical field
The present invention relates to a cover Chinese herbal medicine formula, relate in particular to the medicine of a cover treatment rheumatoid arthritis, ankylosing spondylitis.
Background technology
Rheumatoid arthritis, ankylosing spondylitis belong to the osteoarthrosis arthromyodynia together, and patient is very painful, and particularly the rheumatoid arthritis sickness rate is higher, and at present for the treatment of above-mentioned disease, though Chinese medicine, Western medicine are a lot, do not have a kind of specific drug.
Summary of the invention
The objective of the invention is at above-mentioned disease, the treatment rheumatoid arthritis of a cover Chinese herbal medicine formula composition, the medicine of ankylosing spondylitis are provided, this cover medicine is made up of following two groups of medicines.
For achieving the above object, the present invention has adopted following technical scheme to realize.The present invention adopts two kinds " attacking method " of the Chinese herbal medicine wheel stream treatment of two kinds of prescriptions according to traditional Chinese medical science internal treatment's theory of " treating cold syndrome with hot-nature drugs, treating heat syndrome with cold-natured drugs, strengthening vital QI to eliminate pathogenic factors ", reaches the curative effect of taking stopgap measures and effecting a permanent cure.
Every percent by weight proportioning of the present invention is:
First group: red Cuculus polioephalus root 70-90, Fructus Fici 10-20.
Second group: Radix Ophiopogonis 70-90; Radix Glycyrrhizae 10-20.
Processing technology of the present invention is:
First group: water decocts.Press proportioning earlier with red Cuculus polioephalus root, Fructus Fici is cleaned and is put into jar, and it is an amount of to add water, and after warm fire decocted half an hour, drop went out stand-by.Decoct 40 minutes for the second time, for the third time, decoct one hour the 4th time, drop juice day clothes.
Second group: water decocts.Press proportioning earlier with Radix Ophiopogonis, Radix Glycyrrhizae is cleaned and puts into jar, and it is an amount of to add water, and after warm fire decocted half an hour, drop went out stand-by.Decoct 40 minutes for the second time, for the third time, decoct one hour the 4th time, drop juice day clothes.
Instructions of taking of the present invention is: took first group of magistral medicines earlier one month, took second group of magistral medicines most 10 days, took first group of magistral medicines then most one month, take secondary so in turn and can take effect.
Pharmacology analysis of the present invention.(1), red Cuculus polioephalus root, Fructus Fici, warm in nature, wind-damp dispelling, cold expelling remove evil, phlegm reduction of blood circulation promoting, blood stasis-eliminating and stagnation-dissipating, pain relieving is good for the stomach.(2), Radix Ophiopogonis, Radix Glycyrrhizae, property is hot cold, heat-clearing and toxic substances removing, wind-damp dispelling, alleviating pain and detumescence.
The present invention compared with prior art, has following obvious advantage:, be carrying out property the person of increasing the weight of is more and see, particularly rheumatoid arthritis because the morbidity of rheumatoid arthritis, ankylosing spondylitis system is slower, and the present invention has tangible blood circulation promoting and blood stasis dispelling, the analgesic antiphlogistic effect.The present invention also has wind-cold damp pathogen in the body of dispeling, and the function that is good for the stomach is so therapeutic effect is obvious.Generally take medicine 2-4 the course of treatment, just can reach therapeutic purposes.The present invention is applicable to treatment rheumatoid arthritis, ankylosing spondylitis patient.
The specific embodiment
Embodiment one: get red Cuculus polioephalus root 90 grams; Fructus Fici 10 grams are put into medicinal cupping, and it is an amount of to add water, and warm fire decocts 30 minutes, and drop goes out stand-by.Respectively fried in shallow oil 40 minutes for the second time, for the third time, fried in shallow oil one hour for the 4th time, drop juice promptly.
Embodiment two: get red Cuculus polioephalus root 85 grams; Fructus Fici 15 grams are put into medicinal cupping, and it is an amount of to add water, and warm fire decocts 30 minutes, and drop goes out stand-by.Respectively fried in shallow oil 40 minutes for the second time, for the third time, fried in shallow oil one hour for the 4th time, drop juice promptly.
Embodiment three: get red Cuculus polioephalus root 80 grams; Fructus Fici 20 grams are put into medicinal cupping, and it is an amount of to add water, and warm fire decocts 30 minutes, and drop goes out stand-by.Respectively fried in shallow oil 40 minutes for the second time, for the third time, fried in shallow oil one hour for the 4th time, drop juice promptly.
At the medicine of taking said ratio after one month, change the medicine 10 days of stating proportioning again.
Embodiment four: get Radix Ophiopogoniss 90 gram, Radix Glycyrrhizae 10 grams are put into medicinal cupping, and it is an amount of to add water, and warm fire decocts 30 minutes, and drop goes out stand-by.Respectively fried in shallow oil 40 minutes for the second time, for the third time, fried in shallow oil one hour for the 4th time, drop juice promptly.
Embodiment five: get Radix Ophiopogoniss 85 gram, Radix Glycyrrhizae 15 grams are put into medicinal cupping, and it is an amount of to add water, and warm fire decocts 30 minutes, and drop goes out stand-by.Respectively fried in shallow oil 40 minutes for the second time, for the third time, fried in shallow oil one hour for the 4th time, drop juice promptly.
Embodiment six: get Radix Ophiopogoniss 80 gram, Radix Glycyrrhizae 20 grams are put into medicinal cupping, and it is an amount of to add water, and warm fire decocts 30 minutes, and drop goes out stand-by.Respectively fried in shallow oil for the third time 40 minutes for the second time.Fried in shallow oil one hour for the 4th time, drop juice promptly.
The present invention is applicable to treatment rheumatoid arthritis, ankylosing spondylitis patient.

Claims (2)

1, a cover treatment rheumatoid arthritis, ankylosing spondylitis medicine is characterized in that this cover medicine, are made up of two groups of medicines:
First group of medicine is that the Fructus Fici of 10-20 percent by weight proportioning is made by the red Cuculus polioephalus root of 70-90 percent by weight proportioning;
Second group of medicine is the Radix Ophiopogonis by 70-90 percent by weight proportioning, and the Radix Glycyrrhizae of 10-20 percent by weight proportioning is made.
2, the medicine of a cover treatment rheumatoid arthritis according to claim 1, ankylosing spondylitis, it is characterized in that this cover medicine processing technology is: first group of medicine: water decocts, by weight ratio red Cuculus polioephalus root, Fructus Fici are cleaned earlier and put into jar, it is an amount of to add water, after the temperature fire decocted half an hour, drop went out stand-by; Decoct 40 minutes for the second time, for the third time, decoct one hour the 4th time, drop juice promptly, second group of medicine: water decocts, earlier by weight ratio with Radix Ophiopogonis, Radix Glycyrrhizae is cleaned and puts into jar, it is an amount of to add water, after warm fire decocted half an hour, drop went out stand-by; Decoct 40 minutes for the second time, for the third time, decoct one hour the 4th time, drop juice promptly.
CN 02112177 2002-06-21 2002-06-21 Medicine for treating rheumatoid arthritis and tetanic rachitis Expired - Fee Related CN1197599C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 02112177 CN1197599C (en) 2002-06-21 2002-06-21 Medicine for treating rheumatoid arthritis and tetanic rachitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 02112177 CN1197599C (en) 2002-06-21 2002-06-21 Medicine for treating rheumatoid arthritis and tetanic rachitis

Publications (2)

Publication Number Publication Date
CN1435205A CN1435205A (en) 2003-08-13
CN1197599C true CN1197599C (en) 2005-04-20

Family

ID=27628316

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 02112177 Expired - Fee Related CN1197599C (en) 2002-06-21 2002-06-21 Medicine for treating rheumatoid arthritis and tetanic rachitis

Country Status (1)

Country Link
CN (1) CN1197599C (en)

Also Published As

Publication number Publication date
CN1435205A (en) 2003-08-13

Similar Documents

Publication Publication Date Title
CN1079152A (en) Preparation method of quick-acting bone injury medicine
CN101129741A (en) Heat-clearing and eruption-promoting liquid
CN102652805A (en) Medicine for treating rabies
CN1814245A (en) Chinese medicine remedy for treating cervical vertebra disease
CN1251736C (en) Chinese medicinal infusion for treating shingles, parotitis acute mamitis and its manufacturing method
CN101129852A (en) Oral liquid for regulating qi and tranquilizing mind
CN102552707B (en) Medicinal preparation for treating migraine
CN1270759C (en) Cocklebur fruit and magnolia flower contained ointment for treating chronic rhinitis and its preparing process
CN1197599C (en) Medicine for treating rheumatoid arthritis and tetanic rachitis
CN100349606C (en) Drug tincture for treating flat wart, and preparation method
CN1729992A (en) External bath lotion for epidemic common cold due to wind-cold
CN101129512A (en) Oral liquid of herba lycopi and angelica
CN1097623A (en) Treatment chronic nephritis, uremic Chinese medicine preparation and preparation method thereof
CN1322558A (en) Liver cancer resisting medicine
CN1057912C (en) "Danshenye" Chinese medicinal liquid for treatment of cholecystitis
CN1669571A (en) Chinese traditional medicine for treating enteritis and appendicitis, and method for preparing same
CN1342478A (en) Medical wine for treating rheumatism
CN101129571A (en) Prunellae Spica oral liquid
CN1294984C (en) Combination of Chinese traditional medicine for treating rheumatoid arthritis and artjritis pauperum
CN1380082A (en) Chinese medicine for curing female chronic inflammation
CN1742860A (en) Enema for treating pelvic inflammation and preparing method
CN1468621A (en) Medicine for treating hyperosteogeny
CN1069204C (en) External use liniment for rheumatism made of natural plant material
CN1062765C (en) Jaundice diminishing medicine good for liver
CN104524414A (en) Traditional Chinese medicine preparation for treating chronic gastritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20050420

Termination date: 20120621